Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-07
1995-12-26
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
424450, 424486, 424488, 424491, 424492, 424497, 424499, 546106, A61K 3144
Patent
active
054788374
ABSTRACT:
Compositions and methods for prevention of adhesion formation, whereby an effective amount of quinacrine as active agent is administered for a period of time sufficient to permit tissue repair. The active agent is preferably administered in conjunction with a delivery vehicle (e.g., microcapsules, microspheres, lipid-based systems, viscous instillates and absorbable mechanical barriers) useful for maintaining local concentrations of the compound at an effective level.
REFERENCES:
patent: 4158050 (1979-06-01), Zipper
patent: 4181725 (1980-01-01), Voorhees et al.
patent: 4185618 (1980-01-01), Corey
patent: 4937254 (1990-06-01), Sheffield et al.
diZerega, G. S. & Rodgers, K. E., "Prevention of Postoperative Adhesions," in The Peritoneum, diZerega, G. S. & Rodgers, K. E., eds., Springer-Verlag, New York, pp. 307-369 (1992).
Elkins, T. E., "Can a Pro-Coagulant Substance Prevent Adhesions?" in Treatment of Post-Surgical Adhesions, diZerega, G. S. et al., eds., Wiley-Liss, New York, pp. 103-112 (1990).
Rodgers, K. E., "Nonsteroidal anti-inflammatory drugs (NSAIDs) in the treatment of Postsurgical adhesion," in Treatment of Post-Surgical Adhesions, diZerega, G. S. et al., eds., Wiley-Liss, New York, pp. 119-129 (1990).
Moreno, J. J. et al., "PLA.sub.2 -induced oedema in rat skin and histamine release in rat mast cells. Evidence for involvement of lysophospholipids in the mechanism of action," Agents Actions 36, 258 (1992).
Prowse, C. et al., "Prevention of the platelet alpha-granule release reaction by membrane-active drugs," Thrombosis Research 25, 219 (1982).
Janzing, et al., "Intrapleural quinacrine instillation for recurrent pneumothorax or persistent air leak," Ann. Thoracic Surgery 55, 368 (1993).
Senior et al., "Morphometric and kinetic studies on the change induced in the intestinal mucosa of rats by intraperitoneal administration of quinacrine," Cell & Tissue Kinetics 17, 445 (1984).
Struhar, D. et al., "Quinacrine inhibits oxygen radicals release from human alveolar macrophages," Int. J. Immunopharmac. 14, 275 (1992).
Foeldes-Filep, E. & Filep, J. G., "Mepacrine inhibits fMLP-induced activation of human neutrophil granulocytes, leukotriene B.sub.4 formation, and fMLP binding," J. Leukocyte Biol. 52, 545 (1992).
Rodgers, K. et al., "Effects of tolmetin sodium dihydrate on normal and postsurgical peritoneal cell function," Int. J. Immunopharmac. 10, 111 (1988).
Agrenius, V. et al., "Pleural fibrinolytic activity is decreased in inflammation as demonstrated in quinacrine pleurodesis treatment of malignant pleural effusion," Am. Rev. Respir. Dis. 140, 1381 (1989).
Suzuki, A. et al., "Participation of phospholipase A.sub.2 in induction of tissue plasminogen activator (t-PA) production by human fibroblast, IMR-90 cells, stimulated by proteose peptone," Thromb. Res. 64, 191 (1991).
Mumford, S. D. & Kiesel, E., "Sterilization needs in the 1990s: The case for quinacrine nonsurgical female sterilization," Am. J. Obstet. Gynecol. 167, 1203 (1992).
Lennartz, M. R. & Brown, E. J., "Arachidonic acid is essential for IgG Fc receptor-mediated phagocytosis by human monocytes," J. Immunol. 147, 621 (1991).
Kim, T. K. et al., "Extended-release formulation of morphine for subcutaneous administration," Cancer Chemother. Pharmacol. 33, 187 (1993).
Chatelut, E. et al., "A slow-release methotrexate formulation for intrathecal chemotherapy," Cancer Chemother. Pharmacol. 32, 179 (1993).
Lewis, D. H., "Controlled Release of Bioactive Agents from Lactide/Glycolide Polymers," in Biodegradable polymers as drug delivery systems, Jason & Langer, eds., pp. 1-41 (1990).
Hoeckel, M. et al., "Prevention of Peritoneal Adhesions in the Rat with Sustained Intraperitoneal Dexamethasone Deliverd by a Novel Therapeutic System," Annales Chirurgiae et Gynaecologiae 76:306-313 (1987).
Rodgers, K. et al., "Inhibition of Postsurgical Adhesions by Liposomes Containing Nonsteroidal Antiinflammatory Drugs," Int. J. Fertil. 35:40 (1990).
Abe, H. et al., "The Effect of Intraperitoneal Administration of Sodium Tolmetin-Hyaluronic Acid on the Postsurgical Cell Infiltration In Vivo," J. Surg. Res. 49:322 (1990).
Diamond, M. P. et al., "Synergistic effects of Interceed(TC7) and heparin in reducing adhesion formation in the rabbit uterine horn model," Fertility and Sterility 55, 389 (1991).
Diamond, M. P. et al., "Adhesion reformation: reduction by the use of Interceed(TC7) plus heparin," J. Gynecologic Surg. 7, 1 (1991).
Nishimura, K. et al., "The use of ibuprofen for the prevention of postoperative adhesions in rabbits," Am. J. Med. 77:102-6 (1984).
Interceed (TC7) Adhesion Barrier Study Group, "Prevention of Postsurgical adhesions by Interceed (TC7), an Absorbable Adhesion Barrier: A Prospective, Randomized Multicenter Clinical Study", Fertility and Sterility, 51:933 (1989).
Bjoerkman, S. et al., "Pharmacokinetics of Quinacrine after Intrapleural Instillation in Rabbits and Man", J. Pharm. Pharmacol., 41:160-163 (1988).
Beckman, S. et al., "Possible Involvement of Phospholipase Activation in Erythroid Progenitor Cell Proliferation", Exp. Hematol., 17:309-312 (1989).
diZerega Gere S.
Rodgers Kathleen E.
Hollrah Glennon H.
Rand Scott C.
University of Southern California
LandOfFree
Use of quinacrine in preventing adhesion formation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of quinacrine in preventing adhesion formation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of quinacrine in preventing adhesion formation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1369436